iShares U.S. Pharmaceuticals ETF

NAV as of Jun 24, 2022 $194.43
52 WK: 178.54 - 201.87
1 Day NAV Change as of Jun 24, 2022 4.05 (2.13%)
NAV Total Return as of Jun 23, 2022 YTD: -3.81%

Fees as stated in the prospectus Expense Ratio: 0.42%

Overview

Why IHE?

1. Exposure to U.S. companies that manufacture prescription or over-the-counter drugs or vaccines

2. Targeted access to domestic pharmaceutical stocks

3. Use to express a sector view

INVESTMENT OBJECTIVE

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.

Next: Previous:

Performance

Growth of Hypothetical $10,000

Performance chart data not available for display.

Growth of Hypothetical $10,000
Historical NAVs

iShares U.S. Pharmaceuticals ETF ($)

The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.